Acura Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results
ACURA PHARMS INC (ACUR)
Last acura pharms inc earnings: 8/14 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.acurapharm.com/investor-relations
Company Research
Source: GlobeNewswire
PALATINE, Ill., March 30, 2020 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the research, development and commercialization of technologies and product candidates intended to mitigate the risk of outcomes associated with product misuse, announced today financial results for the three and twelve months ended December 31, 2019. The Company reported an operating income of $0.3 million for the fourth quarter 2019 compared to an operating loss of $0.3 million for the same period in 2018. For the twelve months ended December 31, 2019, the Company reported an operating loss of $0.7 million compared to an operating loss of $4.0 million for the same period in 2018. The Company reported net income of $0.2 million or $0.00 per diluted share for the fourth quarter 2019 compared to net income of $8 thousand or $0.00 per diluted share for the same period in 2018. For the twelve months ended December 31, 2019, the Company reported a net loss of $
Show less
Read more
Impact Snapshot
Event Time:
ACUR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACUR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACUR alerts
High impacting ACURA PHARMS INC news events
Weekly update
A roundup of the hottest topics
ACUR
Sec Filings
- 11/21/24 - Form NT
- 11/4/24 - Form 8-K
- 10/2/24 - Form 8-K
- ACUR's page on the SEC website